Division of Biology, Kansas State University, Manhattan, Kansas, USA.
Langston University, Langston, Oklahoma, USA.
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.02184-19.
Beta genus human papillomaviruses (β-HPVs) cause cutaneous squamous cell carcinomas (cSCCs) in a subset of immunocompromised patients. However, β-HPVs are not necessary for tumor maintenance in the general population. Instead, they may destabilize the genome in the early stages of cancer development. Supporting this idea, β-HPV's 8E6 protein attenuates p53 accumulation after failed cytokinesis. This paper offers mechanistic insight into how β-HPV E6 causes this change in cell signaling. An screen and characterization of HCT 116 cells lacking p300 suggested that the histone acetyltransferase is a negative regulator of Hippo pathway (HP) gene expression. HP activation restricts growth in response to stimuli, including failed cytokinesis. Loss of p300 resulted in increased HP gene expression, including proproliferative genes associated with HP inactivation. β-HPV 8E6 expression recapitulates some of these phenotypes. We used a chemical inhibitor of cytokinesis (dihydrocytochalasin B [H2CB]) to induce failed cytokinesis. This system allowed us to show that β-HPV 8E6 reduced activation of large tumor suppressor kinase (LATS), an HP kinase. LATS is required for p53 accumulation following failed cytokinesis. These phenotypes were dependent on β-HPV 8E6 destabilizing p300 and did not completely attenuate the HP. It did not alter H2CB-induced nuclear exclusion of the transcription factor YAP. β-HPV 8E6 also did not decrease HP activation in cells grown to a high density. Although our group and others have previously described inhibition of DNA repair, to the best of our knowledge, this marks the first time that a β-HPV E6 protein has been shown to hinder HP signaling. β-HPVs contribute to cSCC development in immunocompromised populations. However, it is unclear if these common cutaneous viruses are tumorigenic in the general population. Thus, a more thorough investigation of β-HPV biology is warranted. If β-HPV infections do promote cSCCs, they are hypothesized to destabilize the cellular genome. data support this idea by demonstrating the ability of the β-HPV E6 protein to disrupt DNA repair signaling events following UV exposure. We show that β-HPV E6 more broadly impairs cellular signaling, indicating that the viral protein dysregulates the HP. The HP protects genome fidelity by regulating cell growth and apoptosis in response to a myriad of deleterious stimuli, including failed cytokinesis. After failed cytokinesis, β-HPV 8E6 attenuates phosphorylation of the HP kinase (LATS). This decreases some, but not all, HP signaling events. Notably, β-HPV 8E6 does not limit senescence associated with failed cytokinesis.
β 属人乳头瘤病毒(β-HPV)可导致部分免疫功能低下的患者发生皮肤鳞状细胞癌(cSCC)。然而,β-HPV 并非一般人群中肿瘤维持所必需的。相反,它们可能在癌症发展的早期阶段使基因组不稳定。支持这一观点的是,β-HPV 的 8E6 蛋白在有丝分裂失败后减弱了 p53 的积累。本文提供了有关 β-HPV E6 如何引起细胞信号转导改变的机制见解。对缺乏 p300 的 HCT 116 细胞的筛选和表征表明,组蛋白乙酰转移酶是 Hippo 通路(HP)基因表达的负调节剂。HP 的激活限制了对刺激的生长反应,包括有丝分裂失败。p300 的缺失导致 HP 基因表达增加,包括与 HP 失活相关的促增殖基因。β-HPV 8E6 的表达再现了其中一些表型。我们使用有丝分裂抑制剂(二氢细胞松弛素 B[H2CB])诱导有丝分裂失败。该系统使我们能够表明,β-HPV 8E6 降低了大肿瘤抑制激酶(LATS)的 HP 激酶的激活。LATS 是有丝分裂失败后 p53 积累所必需的。这些表型依赖于β-HPV 8E6 使 p300 不稳定,并且不能完全抑制 HP。它并没有改变转录因子 YAP 在 H2CB 诱导的核排除。β-HPV 8E6 也没有降低细胞生长到高密度时的 HP 激活。尽管我们的小组和其他小组以前已经描述了 DNA 修复的抑制作用,但据我们所知,这是首次表明β-HPV E6 蛋白能够阻碍 HP 信号转导。β-HPV 有助于免疫功能低下人群的 cSCC 发展。然而,尚不清楚这些常见的皮肤病毒是否在一般人群中具有致癌性。因此,需要更彻底地研究β-HPV 的生物学。如果β-HPV 感染确实促进了 cSCC,那么它们被假设为破坏细胞基因组的稳定性。数据通过证明β-HPV E6 蛋白在暴露于 UV 后能够破坏 DNA 修复信号事件来支持这一观点。我们表明,β-HPV E6 更广泛地破坏细胞信号转导,表明病毒蛋白扰乱了 HP。HP 通过调节细胞生长和凋亡来保护基因组的保真度,以响应包括有丝分裂失败在内的多种有害刺激。有丝分裂失败后,β-HPV 8E6 减弱了 HP 激酶(LATS)的磷酸化。这减少了一些,但不是全部,HP 信号事件。值得注意的是,β-HPV 8E6 并不限制与有丝分裂失败相关的衰老。